New England SIREN Group

Our annual Harvard Neurologic Emergencies CME course will be virtual this year, making it easier than ever to join! We have an amazing lineup of speakers, and tons of time for questions, answers, and discussion. Register early and save $$$!!!!

Neurological Emergencies Harvard Medical School CME: Education to Improve Diagnosis of Neurological Symptoms, Rapidly Identify Emergencies, and Optimize Outcomes

What is BOOST-3? BOOST-3 is a research study to learn if either of two strategies for monitoring and treating patients with traumatic brain injury in the ICU is more likely to help them get better. To learn more about this study, please visit: boost3trial.org

What is the best 2nd line treatment for Status Epilepticus (prolonged, refractory seizures) for children and adults? Come read about it here:

Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial Children, adults, and older adults with established status epilepticus respond similarly to levetiracetam, fosphenytoin, and valproate, with treatment success in approximately half of patients. Any of the three drugs can be considered as a potential first-choice, second-line drug for benzodiazepine-...

Want to learn more about Emergency Research? Click on this short video to learn more!

Emergency Research Q/A This is "Emergency Research Q/A" by Joy Black on Vimeo, the home for high quality videos and the people who love them.

Check out an article on a seizure study we completed showing that three medicines commonly used to treat prolonged seizures all work similarly well here: https://www.massgeneral.org/research/news/articles/esett-trial